187 related articles for article (PubMed ID: 9083154)
1. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
[TBL] [Abstract][Full Text] [Related]
3. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma.
Xu HJ; Quinlan DC; Davidson AG; Hu SX; Summers CL; Li J; Benedict WF
J Natl Cancer Inst; 1994 May; 86(9):695-9. PubMed ID: 8158700
[TBL] [Abstract][Full Text] [Related]
4. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.
Harpole DH; Herndon JE; Wolfe WG; Iglehart JD; Marks JR
Cancer Res; 1995 Jan; 55(1):51-6. PubMed ID: 7805040
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer.
Quinlan DC; Davidson AG; Summers CL; Warden HE; Doshi HM
Cancer Res; 1992 Sep; 52(17):4828-31. PubMed ID: 1324796
[TBL] [Abstract][Full Text] [Related]
6. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.
Ebina M; Steinberg SM; Mulshine JL; Linnoila RI
Cancer Res; 1994 May; 54(9):2496-503. PubMed ID: 7909277
[TBL] [Abstract][Full Text] [Related]
7. Expression of ras Rb1 and p53 proteins in human breast cancer.
Spandidos DA; Karaiossifidi H; Malliri A; Linardopoulos S; Vassilaros S; Tsikkinis A; Field JK
Anticancer Res; 1992; 12(1):81-9. PubMed ID: 1567185
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of oncogene product expression in human lung cancer].
Dosaka-Akita H; Harada M; Miyamoto H; Kawakami Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1441-7. PubMed ID: 1331597
[TBL] [Abstract][Full Text] [Related]
9. RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma.
Shimizu E; Coxon A; Otterson GA; Steinberg SM; Kratzke RA; Kim YW; Fedorko J; Oie H; Johnson BE; Mulshine JL
Oncogene; 1994 Sep; 9(9):2441-8. PubMed ID: 8058306
[TBL] [Abstract][Full Text] [Related]
10. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung.
Miyake M; Taki T; Hitomi S; Hakomori S
N Engl J Med; 1992 Jul; 327(1):14-8. PubMed ID: 1317941
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.
Shapiro GI; Edwards CD; Kobzik L; Godleski J; Richards W; Sugarbaker DJ; Rollins BJ
Cancer Res; 1995 Feb; 55(3):505-9. PubMed ID: 7834618
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of relative survival vs. classical survival. Apropos of primary bronchial cancer].
Foucher P; Coudert B; Dramais-Marcel D; Arveux P; Camus P; Jeannin L
Bull Cancer; 1994 Oct; 81(10):857-65. PubMed ID: 7734768
[TBL] [Abstract][Full Text] [Related]
13. Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer.
Rusch V; Klimstra D; Venkatraman E; Oliver J; Martini N; Gralla R; Kris M; Dmitrovsky E
Cancer Res; 1995 Nov; 55(21):5038-42. PubMed ID: 7585548
[TBL] [Abstract][Full Text] [Related]
14. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
15. Relationship between ras oncogene expression and clinical and pathological features of colonic carcinoma.
Michelassi F; Grad G; Erroi F; Roncella M; Romagnoli J; Handcock M
Hepatogastroenterology; 1990 Oct; 37(5):513-6. PubMed ID: 2253930
[TBL] [Abstract][Full Text] [Related]
16. Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma.
Volm M; Hahn EW; Mattern J; Müller T; Vogt-Moykopf I; Weber E
Cancer Res; 1988 May; 48(10):2923-8. PubMed ID: 2834052
[TBL] [Abstract][Full Text] [Related]
17. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.
Slebos RJ; Kibbelaar RE; Dalesio O; Kooistra A; Stam J; Meijer CJ; Wagenaar SS; Vanderschueren RG; van Zandwijk N; Mooi WJ
N Engl J Med; 1990 Aug; 323(9):561-5. PubMed ID: 2199829
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer prognostic factors from the Aichi Cancer Registry.
Kato I; Tominaga S; Ikari A
Jpn J Clin Oncol; 1990 Sep; 20(3):238-45. PubMed ID: 2174996
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of the retinoblastoma gene in ovarian neoplasms and correlation to p53 and K-ras mutations.
Taylor RR; Linnoila RI; Gerardts J; Teneriello MG; Nash JD; Park RC; Birrer MJ
Gynecol Oncol; 1995 Sep; 58(3):307-11. PubMed ID: 7545631
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 protein in gastric carcinomas is not independently prognostic.
Motojima K; Furui J; Kohara N; Ito T; Kanematsu T
Surgery; 1994 Nov; 116(5):890-5. PubMed ID: 7940194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
